Cognitive-Motor Interference in Neurodegenerative Disease: A Narrative Review and Implications for Clinical Management

, , &
Frontiers in Psychology 9 (2018)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.3389/fpsyg.2018.02061

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,202

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Profiles of Cognitive-Motor Interference During Walking in Children: Does the Motor or the Cognitive Task Matter?Nadja Schott & Thomas J. Klotzbier - 2018 - Frontiers in Psychology 9.
Cognitive Impairment and Dementia in Parkinson's Disease.Murat Emre (ed.) - 2010 - Oxford University Press UK.
Misrepresentations about palliative options and prognosis in motor neurone disease: some legal considerations.Charles Foster - 2005 - Journal of Evaluation in Clinical Practice 11 (1):21-25.
The case‐mix of chronic illness hospitalization rates in a managed care population: implications for health management programmes.Ariel Linden & Steven Goldberg - 2007 - Journal of Evaluation in Clinical Practice 13 (6):947-951.
Chronic care management for patients with COPD: a critical review of available evidence.Karin M. M. Lemmens, Lidwien C. Lemmens, José H. C. Boom, Hanneke W. Drewes, Jolanda A. C. Meeuwissen, Lotte M. G. Steuten, Hubertus J. M. Vrijhoef & Caroline A. Baan - 2012 - Journal of Evaluation in Clinical Practice 19 (5):734-752.
Proactive interference and directed forgetting in short-term motor memory.Leslie Burwitz - 1974 - Journal of Experimental Psychology 102 (5):799.
Gene replacement therapy in the central nervous system: Viral vector-mediated therapy of global neurodegenerative disease.Edward A. Neuwelt, Michael A. Pagel, Alfred Geller & Leslie L. Muldoon - 1995 - Behavioral and Brain Sciences 18 (1):1-9.
Chronic kidney disease: appropriateness of therapeutic management and associated factors in the AVENIR study.Nathalie Thilly, Stéphanie Boini, Michèle Kessler, Serge Briançon & Luc Frimat - 2009 - Journal of Evaluation in Clinical Practice 15 (1):121-128.
What catatonia can tell us about “top-down modulation”: A neuropsychiatric hypothesis.Georg Northoff - 2002 - Behavioral and Brain Sciences 25 (5):555-577.
Controlling futures? Online Genetic Testing and Neurodegenerative Disease: Comment on “Personal Genomic Testing, Genetic Inheritance, and Uncertainty”.Narelle Warren & John Gardner - 2017 - Journal of Bioethical Inquiry 14 (4):593-594.
Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis.Ariel Linden - 2006 - Journal of Evaluation in Clinical Practice 12 (2):132-139.
Evaluating disease management programme effectiveness: an introduction to instrumental variables.Ariel Linden & John L. Adams - 2006 - Journal of Evaluation in Clinical Practice 12 (2):148-154.
Is There a Need for Clinical Neuroskepticism?Eran Klein - 2010 - Neuroethics 4 (3):251-259.
The cognitive aspects of motor performances and their bearing on general motor ability.M. Campbell - 1936 - Journal of Experimental Psychology 19 (3):323.
Strengthening the case for disease management effectiveness: un‐hiding the hidden bias.Ariel Linden, John L. Adams & Nancy Roberts - 2006 - Journal of Evaluation in Clinical Practice 12 (2):140-147.

Analytics

Added to PP
2018-10-29

Downloads
17 (#815,534)

6 months
8 (#283,518)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Add more references